Rxo (RXO) Cash from Financing Activities (2021 - 2026)

Rxo (RXO) has 6 years of Cash from Financing Activities data on file, last reported at $28.0 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 300.0% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.0 million (down 98.02% YoY) and the FY2025 annual result came in at $1.0 million, down 99.91% from the prior year.
• Cash from Financing Activities climbed to $28.0 million in Q1 2026, from -$3.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.1 billion in Q3 2024 to a low of -$145.0 million in Q4 2022.
• A 5-year average of $52.3 million and a median of -$3.0 million in 2025 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 417.86% — and 2024, when it surged 27225.0%.
• Tracing RXO's Cash from Financing Activities over 5 years: stood at -$145.0 million in 2022, then jumped by 31.03% to -$100.0 million in 2023, then jumped by 101.0% to $1.0 million in 2024, then plunged by 400.0% to -$3.0 million in 2025, then surged by 1033.33% to $28.0 million in 2026.
• The last three Cash from Financing Activities figures came in at $28.0 million (Q1 2026), -$3.0 million (Q3 2025), and -$3.0 million (Q2 2025), per Business Quant data.